Financial Ratios

ALPHA DRUG INDIA LTD. (AMALGAMATED)

NSE : NABSE : 500006ISIN CODE : INE256B01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE38.650 (0 %)
PREV CLOSE ( ) 38.65
OPEN PRICE ( ) 38.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )38.00 39.75
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2005Mar2004Mar2003
Operational & Financial Ratios
   Earnings Per Share (Rs)-2.340.33-1.15
   CEPS(Rs)-0.400.77-0.65
   DPS(Rs)0.000.000.00
   Book NAV/Share(Rs)15.183.422.98
   Tax Rate(%)0.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-16.4612.36-19.78
   EBIT Margin(%)-2.239.28-21.15
   Pre Tax Margin(%)-6.154.85-28.52
   PAT Margin (%)-6.154.85-28.52
   Cash Profit Margin (%)-1.0411.33-16.17
Performance Ratios
   ROA(%)-6.295.61-21.56
   ROE(%)-14.4810.29-38.66
   ROCE(%)-3.1513.78-19.30
   Asset Turnover(x)1.021.160.76
   Sales/Fixed Asset(x)0.560.510.30
   Working Capital/Sales(x)2.934.354.17
Efficiency Ratios
   Fixed Capital/Sales(x)1.791.973.30
   Receivable days86.0054.1837.42
   Inventory Days73.1051.3176.30
   Payable days128.90111.53109.70
Valuation Parameters
   PER(x)0.0041.450.00
   PCE(x)0.0017.72-7.28
   Price/Book(x)0.003.991.60
   Yield(%)0.000.00
   EV/Net Sales(x)0.702.281.60
   EV/Core EBITDA(x)22.8713.71-16.89
   EV/EBIT(x)-29.5023.30-7.03
   EV/CE(x)0.592.301.12
   M Cap / Sales0.002.121.27
Growth Ratio
   Net Sales Growth(%)10.6071.810.00
   Core EBITDA Growth(%)-79.57401.710.00
   EBIT Growth(%)-126.91173.910.00
   PAT Growth(%)-242.06128.610.00
   EPS Growth(%)-810.28128.610.00
Financial Stability Ratios
   Total Debt/Equity(x)1.000.380.49
   Current Ratio(x)2.081.942.06
   Quick Ratio(x)1.261.301.13
   Interest Cover(x)-0.572.09-2.87
   Total Debt/Mcap(x)0.100.30

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.